JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally

Feb.12
JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT reported record FY2025 revenue and adjusted operating profit, supported by combustible resilience and accelerating reduced-risk product growth. Heated tobacco volumes surged, led by Ploom. The group confirmed a major three-year RRP investment plan and projected further growth in 2026.

Key Points

 

  • Revenue rose 13.4% YoY to JPY 3,467.7 billion (approx. USD 23.1 billion).
  • Adjusted operating profit increased 21.5% to JPY 902.2 billion (approx. USD 6.0 billion); 24.9% growth at constant FX.
  • Profit attributable to owners of the parent reached JPY 510.2 billion (approx. USD 3.4 billion).
  • RRP-related revenue grew 23.9% to JPY 122.5 billion (approx. USD 817 million).
  • Heated products volume increased 38.6% to 11.3 billion units.
  • Combustible tobacco volume rose 1.7% to 563.8 billion units.
  • Ploom AURA was available in 17 markets by year-end 2025.
  • JT committed approximately JPY 800 billion (approx. USD 5.3 billion) to RRP investment (2026–2028).

 


 

2Firsts, February 12, 2026

 

Japan Tobacco Inc. (JT Group) reported record-high financial results for the fiscal year ended December 31, 2025, in its earnings release issued on February 12, 2026, supported by steady combustible performance and accelerated growth in reduced-risk products (RRP).

 

Revenue from continuing operations increased 13.4% year-on-year to JPY 3,467.7 billion (approx. USD 23.1 billion). Adjusted operating profit rose 21.5% to JPY 902.2 billion (approx. USD 6.0 billion), while profit attributable to owners of the parent reached JPY 510.2 billion (approx. USD 3.4 billion). The group announced a planned annual dividend of JPY 234 per share (approx. USD 1.56).

 

Within the Tobacco Business, RRP continued to gain momentum. RRP-related revenue increased 23.9% to JPY 122.5 billion (approx. USD 817 million). Heated tobacco product (HTS) volume, driven primarily by the Ploom brand, rose 38.6% to 11.3 billion units. In Japan, Ploom’s share of the heated tobacco segment increased to 14.4%, reflecting continued consumer adoption.

 

JT Delivers Record FY2025 Results as RRP Accelerates and Ploom Expands Globally
JT RRP KPIs (FY2025 vs. Prior Year). RRP total volume increased 28% year-on-year, while RRP-related revenue rose 24%, driven primarily by continued growth of the Ploom heated tobacco platform.Source: Japan Tobacco Inc., 2025 Full Year Results & 2026 Forecasts Presentation, released February 12, 2026.

 

By the end of 2025, Ploom AURA had been launched in 17 markets, marking a further step in JT’s international expansion of its heated tobacco portfolio.

 

Traditional combustible products remained the primary earnings base. Combustible tobacco volume increased 1.7% to 563.8 billion units, supported in part by the integration of Vector Group in the United States and performance of global flagship brands including Winston and Camel.

 

Strategically, JT completed the transfer of its Pharmaceutical Business to Shionogi & Co., Ltd., sharpening its focus on tobacco and food operations. Under its newly announced Business Plan 2026, the group committed approximately JPY 800 billion (approx. USD 5.3 billion) in investment toward RRP development and market expansion over the 2026–2028 period.

 

For FY2026, JT forecasts revenue of JPY 3,697.0 billion (approx. USD 24.6 billion) and plans to raise its annual dividend to JPY 242 per share (approx. USD 1.61).

 

Further updates and in-depth analysis will follow. Stay tuned to 2Firsts for continued coverage.

 

Cover image sourced from a screenshot of Japan Tobacco Inc.’s “2025 Full Year Results & 2026 Forecasts (All Presentation)” (released February 12, 2026).

 

BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT AGM Highlights Smokeless Strategy, AI Capability and Regulatory Engagement
BAT Chair Luc Jobin told shareholders at the company’s 2026 Annual General Meeting that BAT delivered on its plans in 2025 despite a challenging external environment, with the U.S. business returning to growth, smokeless consumers increasing by more than 15%, improved New Categories contribution, and GBP 6.3 billion returned to shareholders.
Apr.16 by 2FIRSTS.ai
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands Pulls myblu Vape Business From U.S., Citing Prolonged FDA Approval Process
Imperial Brands said it will phase out its myblu vaping business in the United States, citing prolonged FDA approval timelines for new vape products. The company said it will instead focus on modern oral nicotine products in the U.S., including the expansion of its Zone brand and new flavors. While overall next-generation product revenue continued to grow, revenue from the category in the Americas declined sharply.
May.12
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13
FDA Opens Public Comment Period on Draft Guidance for Flavored E-Cigarette Applications
FDA Opens Public Comment Period on Draft Guidance for Flavored E-Cigarette Applications
The U.S. Food and Drug Administration’s Center for Tobacco Products announced an open public comment period for a draft guidance titled Flavored Electronic Nicotine Delivery Systems (ENDS) Premarket Applications – Considerations Related to Youth Risk.
Apr.09 by 2FIRSTS.ai
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Several anti-smoking and health advocacy groups in the Philippines urged the Department of Trade and Industry to take action against tobacco companies accused of violating the Vape Regulation Act of 2022. The groups said three consecutive complaints had been filed involving nicotine pouch brand ZYN and heated tobacco product company IQOS Philippines.
Apr.27 by 2FIRSTS.ai